PHILADELPHIA -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000, and many patients are in the hospital again and again. But a tiny device is ...
Last year during the holidays, R.G. Carver was using a string trimmer to knock down some weeds in his yard when he got into some cactus and got a few needles stuck in his leg. After a few days, his ...
PHILADELPHIA (WPVI) -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000 and many patients are in the hospital again and again. But a tiny device is ...
Abbott ABT recently released favorable data from its GUIDE-HF clinical trial on its small implantable pulmonary pressure sensor, CardioMEMS HF System. This landmark clinical trial is a 1,000 patient ...
St. Jude Medical's CardioMEMS acquisition brought to the Minnesota device a breakthrough heart monitoring device meant to serve as an early alert system for chronic heart failure patients. The FDA ...
After rejecting it the first time, FDA has approved the world’s first implantable wireless heart monitoring device to manage chronic heart failure patients remotely. Though approved, FDA is requiring ...
When Phyllis Brooks came to a local hospital due to shortness of breath, she was transferred to McLaren Greater Lansing Hospital, where further testing confirmed her diagnosis of a heart condition, ...
In a bid to fortify its Heart Failure business, Abbott ABT recently announced the start of the — GUIDE-HF clinical trial — largest heart failure medical device study in the United States. The trial ...
May 28 (Reuters) - St. Jude Medical Inc said on Wednesday it plans to exercise its option to buy the shares of CardioMEMS it does not already own for $375 million following news the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results